Related references
Note: Only part of the references are listed.Gut Microbiota-Stimulated Innate Lymphoid Cells Support beta-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes
Michela Miani et al.
CELL METABOLISM (2018)
The microbiome and autoimmunity: a paradigm from the gut-liver axis
Bo Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
The effect of fucoidan on intestinal flora and intestinal barrier function in rats with breast cancer
Meilan Xue et al.
FOOD & FUNCTION (2018)
Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
Jing Gao et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues
Hsin-Hsien Yu et al.
MARINE DRUGS (2018)
Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes
C. Gar et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2018)
Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells
Tatiana Takiishi et al.
DIABETES (2017)
Dietary fucoidan of Acaudina molpadioides alters gut microbiota and mitigates intestinal mucosal injury induced by cyclophosphamide
Hongjie Shi et al.
FOOD & FUNCTION (2017)
A Novel Combination of Wheat Peptides and Fucoidan Attenuates Ethanol-Induced Gastric Mucosal Damage through Anti-Oxidant, Anti-Inflammatory, and Pro-Survival Mechanisms
Juntao Kan et al.
NUTRIENTS (2017)
Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats
Meilan Xue et al.
PLOS ONE (2017)
Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes
Eliana Marino et al.
NATURE IMMUNOLOGY (2017)
TLR2 and TLR4 expression on CD14(++) and CD14(+) monocyte subtypes in adult-onset autoimmune diabetes
Pavlina Cejkova et al.
BIOMEDICAL PAPERS-OLOMOUC (2016)
Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet
Marco Candela et al.
BRITISH JOURNAL OF NUTRITION (2016)
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
Tommi Vatanen et al.
CELL (2016)
Low molecular weight fucoidan modulates P-selectin and alleviates diabetic nephropathy
Yingjie Xu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Human gut microbes impact host serum metabolome and insulin sensitivity
Helle Krogh Pedersen et al.
NATURE (2016)
The role of the intestinal microbiota in type 1 diabetes mellitus
Mikael Knip et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Altered Macrophage and Dendritic Cell Response in Mif -/- Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 Diabetes
Yuriko Itzel Sanchez-Zamora et al.
JOURNAL OF DIABETES RESEARCH (2016)
Dietary fucoidan modulates the gut microbiota in mice by increasing the abundance of Lactobacillus and Ruminococcaceae
Qingsen Shang et al.
FOOD & FUNCTION (2016)
The gut microbiota and Type 1 Diabetes
Elke Guelden et al.
CLINICAL IMMUNOLOGY (2015)
Fucoidan exerts protective effects against diabetic nephropathy related to spontaneous diabetes through the NF-κB signaling pathway in vivo and in vitro
Yan Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
T1DM and the gut microbiome
Jennifer Sargent
Nature Reviews Endocrinology (2015)
Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling
Agnieszka Plociennikowska et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice
Fernando F. Anhe et al.
GUT (2015)
Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice
Marc Schneeberger et al.
SCIENTIFIC REPORTS (2015)
Therapy of type 1 diabetes with CD4+CD25high CD127-regulatory T cells prolongs survival of pancreatic islets - Results of one year follow-up
Natalia Marek-Trzonkowska et al.
CLINICAL IMMUNOLOGY (2014)
Resident Macrophages Mediate Islet Amyloid PolypeptideInduced Islet IL-1b Production and b-Cell Dysfunction
Clara Y. Westwell-Roper et al.
DIABETES (2014)
Insulin Therapy in Children and Adolescents with Type 1 Diabetes
Faisal S. Malik et al.
PEDIATRIC DRUGS (2014)
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Koji Atarashi et al.
NATURE (2013)
Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes
Min Li et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
NOD Dendritic Cells Stimulated with Lactobacilli Preferentially Produce IL-10 versus IL-12 and Decrease Diabetes Incidence
Jean N. Manirarora et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes
Sridevi Devaraj et al.
CYTOKINE (2011)
Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications
Sridevi Devaraj et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Immune intervention with T regulatory cells: Past lessons and future perspectives for type 1 diabetes
Manuela Battaglia et al.
SEMINARS IN IMMUNOLOGY (2011)
Phenotypical and functional specialization of FOXP3+ regulatory T cells
Daniel J. Campbell et al.
NATURE REVIEWS IMMUNOLOGY (2011)
TLR-dependent T cell activation in autoimmunity
Kingston H. G. Mills
NATURE REVIEWS IMMUNOLOGY (2011)
Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+regulatory T cell function
Donald Cheatem et al.
CLINICAL IMMUNOLOGY (2009)
Control of type 1 diabetes by CD4(+)Foxp3(+) regulatory T cells: lessons from mouse models and implications for human disease
Evridiki Sgouroudis et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes
S. Devaraj et al.
DIABETOLOGIA (2009)
Rabbit Polyclonal Anti-Mouse Thymocyte Globulin Administration Alters Dendritic Cell Profile and Function in NOD Mice to Suppress Diabetogenic Responses
Yanfei Huang et al.
JOURNAL OF IMMUNOLOGY (2009)
Increased toll-like receptor (TLR)2 and TLR4 expression in monocytes from patients with type 1 diabetes: Further evidence of a proinflammatory state
Sridevi Devaraj et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The role of TLR activation in inflammation
I. Sabroe et al.
JOURNAL OF PATHOLOGY (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self
S Sakaguchi
NATURE IMMUNOLOGY (2005)
Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes
S Lindley et al.
DIABETES (2005)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes
EA Green et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
